Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Industry CME Affiliates Would Be Restricted Under Accrediting Proposal

Executive Summary

Continuing medical education providers affiliated with drug manufacturers would be prohibited from conducting CME programs in therapeutic categories where the manufacturer has products under a proposed revision to the Accreditation Council for Continuing Medical Education's standards for providers

You may also be interested in...



Pharma Should Be Excluded From Guideline Development – NEJM Editorial

Standards for the development and adoption of treatment guidelines should be established in light of efforts by industry to manipulate guidelines for commercial purposes, NIH Critical Care Medicine Department senior investigators assert

Pharma Should Be Excluded From Guideline Development – NEJM Editorial

Standards for the development and adoption of treatment guidelines should be established in light of efforts by industry to manipulate guidelines for commercial purposes, NIH Critical Care Medicine Department senior investigators assert

CME Accrediting Proposal Should Clearly Define Conflict Of Interest – PhRMA

The Accreditation Council for Continuing Medical Education's proposed guidelines should include a clear definition of conflict for CME providers, the Pharmaceutical Research & Manufacturers of America says

Related Content

UsernamePublicRestriction

Register

LL1133546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel